Fig. 1From: Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment a Change in representative omental metastasis on CT scan after treatment with durvalumab- tremelimumab on Day 1. Arrows indicate omental metastasis replaced by fatty tissue. Scale bar indicates 25Â mm. b Clinical course of patient until death from neuromuscular respiratory failure on Day 65. Serum CO2 retention is indicative of hypoventilationBack to article page